Special medical purpose infant formula is a powdered or liquid formula designed for the nutritional needs of infants with special medical conditions such as special disorders, diseases or medical conditions. It is mainly aimed at infants aged 0 to 12 months, especially those infants whose nutritional needs cannot be met through ordinary breastfeeding or standard infant formula due to various reasons (such as premature birth, low birth weight, lactose intolerance, food protein allergy, etc.). This type of food is mainly in powdered or liquid form, which is convenient for parents to prepare and use according to the specific situation and needs of the baby. According to the special medical needs of different infants, the nutritional ingredients of special medical purpose infant formula are adjusted and optimized. For example, for infants with lactose intolerance, other carbohydrates may be used completely or partially to replace lactose in the formula; for infants with milk protein allergy, the formula may use partial or deep hydrolysis of milk protein to reduce the allergenicity of milk protein.
The global Special Medical Purpose Infant Formula market size is projected to grow from US$ 7924 million in 2024 to US$ 16470 million in 2030; it is expected to grow at a CAGR of 13.0% from 2024 to 2030.
The 鈥淪pecial Medical Purpose Infant Formula Industry Forecast鈥� looks at past sales and reviews total world Special Medical Purpose Infant Formula sales in 2023, providing a comprehensive analysis by region and market sector of projected Special Medical Purpose Infant Formula sales for 2024 through 2030. With Special Medical Purpose Infant Formula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Special Medical Purpose Infant Formula industry.
This Insight Report provides a comprehensive analysis of the global Special Medical Purpose Infant Formula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Special Medical Purpose Infant Formula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Special Medical Purpose Infant Formula market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Special Medical Purpose Infant Formula and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Special Medical Purpose Infant Formula.
The market for special medical purpose infant formula in my country has grown rapidly in recent years. With the implementation of the three-child policy and the enhancement of the supply capacity of medical services, more and more people need nutritional support clinically, and the demand for special medical food has shown an exponential upward trend. So far, a total of 164 special medical foods have been approved, including 133 domestic products and 31 imported products. These imported products mainly come from the Netherlands, the United Kingdom, Germany, Spain, Switzerland, the United States and other countries. Special medical purpose infant formula is a food designed for the growth needs of infants with special medical conditions. Ordinary infant formula milk powder cannot meet the nutritional needs of such infants. With the increase in clinical demand for nutritional support, the market demand for special medical purpose infant formula will continue to expand.
This report presents a comprehensive overview, market shares, and growth opportunities of Special Medical Purpose Infant Formula market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Lactose-free or Low-lactose
Extended Hydrolysis of Milk Protein
Premature/low Birth Weight Infants
Amino Acid Metabolism Disorders
Breast Milk Nutritional Supplements
Other
Segmentation by Application:
Pediatrics
Neonatal Intensive Care
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Nestle
Danone
Bayer
MeadJohnson
Abbott
Ajinomoto
Fresenius Kabi
Cambrooke Therapeutics
Kate Farms
Glanbia Nutritionals
ProNourish
Real Food Blends
Key Questions Addressed in this Report
What is the 10-year outlook for the global Special Medical Purpose Infant Formula market?
What factors are driving Special Medical Purpose Infant Formula market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Special Medical Purpose Infant Formula market opportunities vary by end market size?
How does Special Medical Purpose Infant Formula break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Special Medical Purpose Infant Formula Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Special Medical Purpose Infant Formula by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Special Medical Purpose Infant Formula by Country/Region, 2019, 2023 & 2030
2.2 Special Medical Purpose Infant Formula Segment by Type
2.2.1 Lactose-free or Low-lactose
2.2.2 Extended Hydrolysis of Milk Protein
2.2.3 Premature/low Birth Weight Infants
2.2.4 Amino Acid Metabolism Disorders
2.2.5 Breast Milk Nutritional Supplements
2.2.6 Other
2.3 Special Medical Purpose Infant Formula Sales by Type
2.3.1 Global Special Medical Purpose Infant Formula Sales Market Share by Type (2019-2024)
2.3.2 Global Special Medical Purpose Infant Formula Revenue and Market Share by Type (2019-2024)
2.3.3 Global Special Medical Purpose Infant Formula Sale Price by Type (2019-2024)
2.4 Special Medical Purpose Infant Formula Segment by Application
2.4.1 Pediatrics
2.4.2 Neonatal Intensive Care
2.4.3 Other
2.5 Special Medical Purpose Infant Formula Sales by Application
2.5.1 Global Special Medical Purpose Infant Formula Sale Market Share by Application (2019-2024)
2.5.2 Global Special Medical Purpose Infant Formula Revenue and Market Share by Application (2019-2024)
2.5.3 Global Special Medical Purpose Infant Formula Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Special Medical Purpose Infant Formula Breakdown Data by Company
3.1.1 Global Special Medical Purpose Infant Formula Annual Sales by Company (2019-2024)
3.1.2 Global Special Medical Purpose Infant Formula Sales Market Share by Company (2019-2024)
3.2 Global Special Medical Purpose Infant Formula Annual Revenue by Company (2019-2024)
3.2.1 Global Special Medical Purpose Infant Formula Revenue by Company (2019-2024)
3.2.2 Global Special Medical Purpose Infant Formula Revenue Market Share by Company (2019-2024)
3.3 Global Special Medical Purpose Infant Formula Sale Price by Company
3.4 Key Manufacturers Special Medical Purpose Infant Formula Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Special Medical Purpose Infant Formula Product Location Distribution
3.4.2 Players Special Medical Purpose Infant Formula Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Special Medical Purpose Infant Formula by Geographic Region
4.1 World Historic Special Medical Purpose Infant Formula Market Size by Geographic Region (2019-2024)
4.1.1 Global Special Medical Purpose Infant Formula Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Special Medical Purpose Infant Formula Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Special Medical Purpose Infant Formula Market Size by Country/Region (2019-2024)
4.2.1 Global Special Medical Purpose Infant Formula Annual Sales by Country/Region (2019-2024)
4.2.2 Global Special Medical Purpose Infant Formula Annual Revenue by Country/Region (2019-2024)
4.3 Americas Special Medical Purpose Infant Formula Sales Growth
4.4 APAC Special Medical Purpose Infant Formula Sales Growth
4.5 Europe Special Medical Purpose Infant Formula Sales Growth
4.6 Middle East & Africa Special Medical Purpose Infant Formula Sales Growth
5 Americas
5.1 Americas Special Medical Purpose Infant Formula Sales by Country
5.1.1 Americas Special Medical Purpose Infant Formula Sales by Country (2019-2024)
5.1.2 Americas Special Medical Purpose Infant Formula Revenue by Country (2019-2024)
5.2 Americas Special Medical Purpose Infant Formula Sales by Type (2019-2024)
5.3 Americas Special Medical Purpose Infant Formula Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Special Medical Purpose Infant Formula Sales by Region
6.1.1 APAC Special Medical Purpose Infant Formula Sales by Region (2019-2024)
6.1.2 APAC Special Medical Purpose Infant Formula Revenue by Region (2019-2024)
6.2 APAC Special Medical Purpose Infant Formula Sales by Type (2019-2024)
6.3 APAC Special Medical Purpose Infant Formula Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Special Medical Purpose Infant Formula by Country
7.1.1 Europe Special Medical Purpose Infant Formula Sales by Country (2019-2024)
7.1.2 Europe Special Medical Purpose Infant Formula Revenue by Country (2019-2024)
7.2 Europe Special Medical Purpose Infant Formula Sales by Type (2019-2024)
7.3 Europe Special Medical Purpose Infant Formula Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Special Medical Purpose Infant Formula by Country
8.1.1 Middle East & Africa Special Medical Purpose Infant Formula Sales by Country (2019-2024)
8.1.2 Middle East & Africa Special Medical Purpose Infant Formula Revenue by Country (2019-2024)
8.2 Middle East & Africa Special Medical Purpose Infant Formula Sales by Type (2019-2024)
8.3 Middle East & Africa Special Medical Purpose Infant Formula Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Special Medical Purpose Infant Formula
10.3 Manufacturing Process Analysis of Special Medical Purpose Infant Formula
10.4 Industry Chain Structure of Special Medical Purpose Infant Formula
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Special Medical Purpose Infant Formula Distributors
11.3 Special Medical Purpose Infant Formula Customer
12 World Forecast Review for Special Medical Purpose Infant Formula by Geographic Region
12.1 Global Special Medical Purpose Infant Formula Market Size Forecast by Region
12.1.1 Global Special Medical Purpose Infant Formula Forecast by Region (2025-2030)
12.1.2 Global Special Medical Purpose Infant Formula Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Special Medical Purpose Infant Formula Forecast by Type (2025-2030)
12.7 Global Special Medical Purpose Infant Formula Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Nestle
13.1.1 Nestle Company Information
13.1.2 Nestle Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.1.3 Nestle Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Nestle Main Business Overview
13.1.5 Nestle Latest Developments
13.2 Danone
13.2.1 Danone Company Information
13.2.2 Danone Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.2.3 Danone Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Danone Main Business Overview
13.2.5 Danone Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.3.3 Bayer Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 MeadJohnson
13.4.1 MeadJohnson Company Information
13.4.2 MeadJohnson Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.4.3 MeadJohnson Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 MeadJohnson Main Business Overview
13.4.5 MeadJohnson Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.5.3 Abbott Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Ajinomoto
13.6.1 Ajinomoto Company Information
13.6.2 Ajinomoto Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.6.3 Ajinomoto Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Ajinomoto Main Business Overview
13.6.5 Ajinomoto Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.7.3 Fresenius Kabi Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Cambrooke Therapeutics
13.8.1 Cambrooke Therapeutics Company Information
13.8.2 Cambrooke Therapeutics Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.8.3 Cambrooke Therapeutics Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Cambrooke Therapeutics Main Business Overview
13.8.5 Cambrooke Therapeutics Latest Developments
13.9 Kate Farms
13.9.1 Kate Farms Company Information
13.9.2 Kate Farms Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.9.3 Kate Farms Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Kate Farms Main Business Overview
13.9.5 Kate Farms Latest Developments
13.10 Glanbia Nutritionals
13.10.1 Glanbia Nutritionals Company Information
13.10.2 Glanbia Nutritionals Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.10.3 Glanbia Nutritionals Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Glanbia Nutritionals Main Business Overview
13.10.5 Glanbia Nutritionals Latest Developments
13.11 ProNourish
13.11.1 ProNourish Company Information
13.11.2 ProNourish Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.11.3 ProNourish Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 ProNourish Main Business Overview
13.11.5 ProNourish Latest Developments
13.12 Real Food Blends
13.12.1 Real Food Blends Company Information
13.12.2 Real Food Blends Special Medical Purpose Infant Formula Product Portfolios and Specifications
13.12.3 Real Food Blends Special Medical Purpose Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Real Food Blends Main Business Overview
13.12.5 Real Food Blends Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
